Etoposide Sandoz 20 mg/ml koncentrat za otopinu za infuziju
Name | Etoposide Sandoz 20 mg/ml koncentrat za otopinu za infuziju |
---|---|
Former Name | Etoposide Ebewe 20 mg/ml koncentrat za otopinu za infuziju |
Marketing Authorisation Number | HR-H-578166910 |
Active Substance | etopozid |
Composition | 1 ml koncentrata za otopinu za infuziju sadrži 20 mg etopozida |
Pharmaceutical Form | koncentrat za otopinu za infuziju |
Manufacturer | Ebewe Pharma GmbH Nfg. KG, Unterach am Attersee, Austrija Fareva Unterach GmbH, Unterach, Austrija |
Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
Marketing Authorisation Date | 28.05.2018 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/178 |
Registration Number | 381-12-01/38-18-08 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L01CB01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o riziku od reakcija preosjetljivosti povezanih s infuzijom lijekova koji sadrže etopozid, kada se primjenjuju s ugrađenim filtrima | 18.01.2024 | Sandoz d.o.o. |